Store besparelser
Hurtig levering
Fri fragt over 499,-
Gemte
Log ind
0
Kurv
Kurv
Bayesian Designs for Phase I-II Clinical Trials
Engelsk
Foto på vej
Specifikationer
Sprog:
Engelsk
Sider:
324
ISBN-13:
9781032242644
Indbinding:
Paperback
Udgave:
ISBN-10:
1032242647
Kategori:
Udg. Dato:
13 dec 2021
Længde:
0mm
Bredde:
156mm
Højde:
234mm
Forlag:
Taylor & Francis Ltd
Serie:
Chapman & Hall/CRC Biostatistics Series
Oplagsdato:
13 dec 2021

Bayesian Designs for Phase I-II Clinical Trials

Engelsk
Paperback
Format:

Om denne bog

Reliably optimizing a new treatment in humans is a critical first step in clinical evaluation since choosing a suboptimal dose or schedule may lead to failure in later trials. At the same time, if promising preclinical results do not translate into a real treatment advance, it is important to determine this quickly and terminate the clinical evaluation process to avoid wasting resources.

Bayesian Designs for Phase I–II Clinical Trials describes how phase I–II designs can serve as a bridge or protective barrier between preclinical studies and large confirmatory clinical trials. It illustrates many of the severe drawbacks with conventional methods used for early-phase clinical trials and presents numerous Bayesian designs for human clinical trials of new experimental treatment regimes.

Written by research leaders from the University of Texas MD Anderson Cancer Center, this book shows how Bayesian designs for early-phase clinical trials can explore, refine, and optimize new experimental treatments. It emphasizes the importance of basing decisions on both efficacy and toxicity.


Forlags Vejl. pris
400,73 kr
Hos Booktok
468 kr
Læg i kurv nu
Sikker betaling
23 - 25 hverdage

Specifikationer
Sprog:
Engelsk
Sider:
324
ISBN-13:
9781032242644
Indbinding:
Paperback
Udgave:
ISBN-10:
1032242647
Kategori:
Udg. Dato:
13 dec 2021
Længde:
0mm
Bredde:
156mm
Højde:
234mm
Forlag:
Taylor & Francis Ltd
Serie:
Chapman & Hall/CRC Biostatistics Series
Oplagsdato:
13 dec 2021
Finder produkter...
Kategori sammenhænge